InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Monday, 09/26/2022 7:54:49 PM

Monday, September 26, 2022 7:54:49 PM

Post# of 426487
CAPT....from your QUOTE on Stocktwits...A clear and concise explanation of the MOA of Vascepa...

"When it comes to LDL-C, the lower the better. Statins and new LDL-C lowering therapies like PCSK-9’s can’t eliminate all cholesterol formation, nor would you want them to because they are essential for many cellular functions. However excess cholesterol particles lead to the formation of Cholesterol Crystals which is the cause of inflammation and plaque formation. EPA BLOCKS this propagation, NOT DHA. This may be the hidden MOA for VASCEPA® which is separate and distinct from the LDL-C lowering pathway.

We now know why R-IT was so effective in reducing CVD ...and it was certainly not because of the MO placebo!




"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News